Cantor Fitzgerald Maintains Overweight on AvePoint, Raises Price Target to $10
Cantor Fitzgerald Maintains Overweight on AvePoint, Raises Price Target to $10
坎托·菲茨杰拉德维持对AvePoint的增持,将目标股价提高至10美元
Cantor Fitzgerald analyst Brett Knoblauch maintains AvePoint (NASDAQ:AVPT) with a Overweight and raises the price target from $8 to $10.
坎托·菲茨杰拉德分析师布雷特·诺布劳赫维持AvePoint(纳斯达克股票代码:AVPT)的增持,并将目标股价从8美元上调至10美元。
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。